Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Hair proteins in preschool children and their mothers could indicate developmental changes and health status.

Early baldness and little chest hair may indicate higher prostate cancer risk.

PON1 levels might indicate hair loss severity, but other health factors can affect this.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Men with male pattern baldness have higher blood sugar, bad cholesterol, and ZAG protein levels than healthy men.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Higher Interleukin 17A levels may indicate more severe alopecia areata.

Acne patients have higher mTOR gene expression.

Hair follicle sampling is a practical method for measuring biomarkers in children with and without Fragile X syndrome.

Hair follicle sampling is a feasible method to measure FMRP and FMR1 mRNA levels in children.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Higher IL-17A levels indicate more severe alopecia areata.

Mothers have more hair proteins than their children, with age-related differences in protein patterns, and some proteins in hair could indicate early childhood development.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

People with pattern hair loss have higher polyamine levels in the top of their head compared to the back.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Hair cortisol content can indicate cortisol exposure and varies with age, puberty, and BMI in youth.

Hair is important for aging and cancer treatment, affecting emotions, culture, and health.

Fumaric acid esters, especially dimethylfumarate, improve psoriasis treatment.

DHCer levels in hair could be a biomarker for alopecia progression.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Hair cortisol measurement is a promising, non-invasive tool for monitoring cortisol exposure over time.

Early changes in skin gene expression can predict later bone mass loss after radiation exposure.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.